The global histology and cytology market size is expected to
reach USD 30.6 billion by 2026, based on a new report by Grand View Research,
Inc. It is projected to expand at a CAGR of 13.7% during the forecast period.
Increasing incidence of cancer coupled with growing adoption of cytological
test due to its high reliability and less invasive nature as compared to biopsy
is likely to drive the growth.
Furthermore, rising number of
well-equipped clinical laboratories in developing countries and favorable
reimbursement for cancer screening and laboratory tests are likely to
positively affect market growth. Advancements in cytology and histology save
the time for pathologists, making the service more cost-effective.
Technological advancements and launch
of new products are the high impact rendering drivers for the histology and
cytology market. In March 2018, Roche launched VENTANA DP 200 slide scanner. It
is a high-speed slide scanner for digital pathology. The scanner reduces
workflow errors and improves image quality. In March 2016, Becton, Dickinson
and Company received approval from the U.S. FDA for its automated cervical
cancer screening systems, namely BD Totalys MultiProcessor and BD Totalys
SlidePrep. These instruments are used for gynecological specimen preparation.
In February 2014, Roche launched a new
test for cervical cancer screening, Automated CINtec PLUS cytology test, which
improves detection of cervical precancer. In March 2018, BD Life Sciences-Diagnostic
Systems launched BD SurePath, a liquid-based cytology test in India for
screening and detection of cervical cancer, precancerous lesions, and other
cytological categories.
Browse full research report on Histology and Cytology Market:
Further key findings from the study suggest:
- Cytology testing led the market in 2018, attributed to high
disease prevalence and adoption of the test for cervix screening. The
segment is expected to maintain its position during the forecast period
due to the recent entry of various tests and advantages over histology such
as faster analysis and cost-effectiveness
- The U.S. histology and cytology market was the largest in
2018 and is expected to maintain its dominance during the forecast period
due to higher awareness about screening and higher healthcare expenditure
as compared to the developing countries
- Asia Pacific is projected to witness substantial growth over
the next decade owing to growing investment by several clinics in the
region, growing healthcare expenditure, and adoption of screening tests
- Some of the key players operating in the market are Abbott
Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.;
Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo
Fisher Scientific, Inc.; and Trivitron Healthcare.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/histology-and-cytology-market/request/rs1
Grand View Research has segmented the global histology and
cytology market by type of examination and region:
Histology and Cytology Type of Examination Outlook (Revenue, USD
Million, 2015 - 2026)
- Cytology
- Cervical
Cancer
- Breast
Cancer
- Other
Cancers
- Histology
Histology and Cytology Region Outlook (Revenue, USD Million, 2015
- 2026)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment